India markets close in 4 hours 22 minutes

Medtronic plc (MDT)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
131.31+0.63 (+0.48%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5176.47B
Enterprise value 3193.23B
Trailing P/E 49.36
Forward P/E 120.91
PEG Ratio (5 yr expected) 12.04
Price/sales (ttm)5.86
Price/book (mrq)3.44
Enterprise value/revenue 36.42
Enterprise value/EBITDA 723.68

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 334.91%
S&P500 52-week change 333.41%
52-week high 3132.30
52-week low 395.96
50-day moving average 3126.54
200-day moving average 3122.59

Share statistics

Avg vol (3-month) 34.25M
Avg vol (10-day) 33.3M
Shares outstanding 51.34B
Implied shares outstanding 6N/A
Float 1.34B
% held by insiders 10.08%
% held by institutions 183.70%
Shares short (14-Jul-2021) 411.05M
Short ratio (14-Jul-2021) 42.83
Short % of float (14-Jul-2021) 40.82%
Short % of shares outstanding (14-Jul-2021) 40.82%
Shares short (prior month 14-Jun-2021) 48.74M

Dividends & splits

Forward annual dividend rate 42.52
Forward annual dividend yield 41.92%
Trailing annual dividend rate 32.32
Trailing annual dividend yield 31.78%
5-year average dividend yield 42.08
Payout ratio 487.22%
Dividend date 315-Jul-2021
Ex-dividend date 423-Jun-2021
Last split factor 22:1
Last split date 326-Sep-1999

Financial highlights

Fiscal year

Fiscal year ends 29-Apr-2021
Most-recent quarter (mrq)29-Apr-2021

Profitability

Profit margin 11.97%
Operating margin (ttm)18.13%

Management effectiveness

Return on assets (ttm)3.71%
Return on equity (ttm)7.08%

Income statement

Revenue (ttm)30.12B
Revenue per share (ttm)22.39
Quarterly revenue growth (yoy)36.50%
Gross profit (ttm)19.76B
EBITDA 8.16B
Net income avi to common (ttm)3.61B
Diluted EPS (ttm)2.66
Quarterly earnings growth (yoy)110.50%

Balance sheet

Total cash (mrq)10.82B
Total cash per share (mrq)8.05
Total debt (mrq)27.4B
Total debt/equity (mrq)53.11
Current ratio (mrq)2.65
Book value per share (mrq)38.22

Cash flow statement

Operating cash flow (ttm)6.24B
Levered free cash flow (ttm)4.77B